Bladder Biopsy of Normal-Appearing Mucosa is Not Helpful in Patients with Unexplained Positive Cytology after Nonmuscle Invasive Bladder Cancer
Authors:
- 1 January 2015
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 193 (1) , 48-52
Abstract
Malignant voided cytology with normal endoscopic evaluation represents a diagnostic and therapeutic challenge in many patients with a history of nonmuscle invasive bladder cancer. Bladder biopsy is often advised but its efficacy is unclear. We evaluated the usefulness of bladder biopsy in patients with unexplained positive cytology and describe recurrence patterns in this unique patient subset. From an institutional database we retrospectively identified patients with a history of nonmuscle invasive bladder cancer and surveillance cystoscopy from 2008 to 2012 who had malignant voided urine cytology but normal cystoscopy. Patients underwent systematic bladder biopsy or cystoscopic surveillance and were followed for recurrence and progression. Of 444 patients 343 were followed with surveillance only and 101 underwent a total of 118 biopsies of normal-appearing bladder mucosa. Three biopsies (2.5%) showed carcinoma in situ and none revealed invasive carcinoma. During the median 32-month followup recurrence developed in the bladder in 194 patients (44%), in the upper tract in 24 (5%) and in the prostatic urethra in 5 (1%) while 219 (49%) had no recurrence. A previous diagnosis of upper tract urothelial carcinoma and a history of bacillus Calmette-Guérin treatment were associated with an increased recurrence risk on multivariate analysis. Recurrence rates and patterns were similar in the biopsy and surveillance groups. Patients with malignant cytology despite normal cystoscopy have a high recurrence rate. Biopsy of normal-appearing bladder mucosa in this setting is rarely positive and does not alter the recurrence pattern.Keywords
This publication has 11 references indexed in Scilit:
- Office-based Management of Nonmuscle Invasive Bladder CancerUrologic Clinics of North America, 2013
- EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013European Urology, 2013
- Bladder CancerJournal of the National Comprehensive Cancer Network, 2013
- Clinically unconfirmed positive urinary cytology: diagnostic implications and oncological outcomesBJU International, 2011
- Bladder cancer in cystoscopically normal‐appearing mucosa: a case of mistaken identity?BJU International, 2010
- Economic aspects of bladder cancer: what are the benefits and costs?World Journal of Urology, 2009
- A Phase III, Multicenter Comparison of Hexaminolevulinate Fluorescence Cystoscopy and White Light Cystoscopy for the Detection of Superficial Papillary Lesions in Patients With Bladder CancerJournal of Urology, 2007
- Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markersUrology, 2005
- The economic consequences of prostate and bladder cancer in the UKBJU International, 2004
- Significance of Random Bladder Biopsies in Superficial Bladder CancerEuropean Urology, 2003